Ionis Pharmaceuticals Financial Overview
Ionis Pharmaceuticals's market cap is currently $13.06B. The company's EPS TTM is $-0.8; its P/E ratio is -47.13; Ionis Pharmaceuticals is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $-1.31. See an overview of income statement, balance sheet, and cash flow financials.
